인공 피부 대체재 시장 규모, 점유율 및 동향 분석 보고서 : 해부학적 치환 부위별, 용도별, 최종 용도별 및 지역별 부문 예측(2026-2033년)

Synthetic Skin Substitutes Market Summary

The global synthetic skin substitutes market size was estimated at USD 537.66 million in 2025 and is projected to reach USD 1,505.36 million by 2033, growing at a CAGR of 12.99% from 2026 to 2033. The market is primarily driven by the rising incidence of burns, chronic wounds, diabetic foot ulcers, and traumatic injuries requiring advanced wound care solutions.

The increasing prevalence of diabetes and an aging population further contribute to the growing demand for effective skin regeneration products. Technological advancements in biomaterials and tissue engineering are improving product efficacy and healing outcomes. In addition, expanding healthcare infrastructure and greater awareness of advanced wound management therapies are driving global market growth.

The increasing incidence of burns, traumatic injuries, surgical wounds, and chronic ulcers is significantly driving the demand for synthetic skin substitutes. Severe and partial-thickness burns require immediate wound coverage to reduce fluid loss, prevent infections, and accelerate healing, where synthetic skin substitutes offer an effective temporary or permanent solution. In addition, rising cases of road accidents, diabetic foot ulcers, and pressure sores further boost the need for advanced wound care products. As healthcare systems focus on faster recovery and improved patient outcomes, the synthetic skin substitute market continues to expand.

The rising prevalence of diabetes and other chronic diseases is a major driver of the synthetic skin substitute market, as these conditions often lead to slow-healing wounds such as diabetic foot ulcers and pressure sores. Patients with diabetes experience impaired blood circulation and reduced immune response, increasing the risk of chronic wounds and infections. Synthetic skin substitutes help promote tissue regeneration, maintain a moist wound environment, and accelerate healing. With the global burden of chronic diseases significantly increasing, demand for advanced wound care solutions continues to grow.

Global Synthetic Skin Substitutes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global synthetic skin substitutes market report on the basis of anatomical replacement area, application, end use, and region:

• Anatomical Replacement Area Outlook (Revenue, USD Million, 2021 - 2033)
• Dermal Substitutes
• Epidermal Substitutes
• Full-Thickness (Composite)
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Chronic Wounds
  • Diabetic Foot Ulcer (DFUs)
  • Venous Leg Ulcer (VLUs)
  • Pressure Ulcers
• Acute Wounds
  • Burn Injuries
  • Surgical Wounds
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics & Wound Care Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Anatomical Replacement Area
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Synthetic Skin Substitutes Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing incidence of burns and wounds
    • 3.2.1.2. Rising prevalence of diabetes and chronic diseases
    • 3.2.1.3. Growing awareness and adoption of advanced wound care
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of products
    • 3.2.2.2. Stringent regulatory requirements
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Rising prevalence of chronic wounds
    • 3.2.3.2. Expansion of home healthcare and outpatient care
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Risk of infection or graft failure
    • 3.2.4.2. Competition from alternative treatments
• 3.3. Synthetic Skin Substitutes Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Synthetic Skin Substitutes Market: Anatomical Replacement Area Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Synthetic Skin Substitutes Market: Anatomical Replacement Area Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Synthetic Skin Substitutes Market Size & Trend Analysis, by Anatomical Replacement Area, 2021 to 2033 (USD Million)
• 4.4. Dermal Substitutes
  • 4.4.1. Dermal substitutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Epidermal Substitutes
  • 4.5.1. Epidermal substitutes Synthetic skin substitutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Full-Thickness (Composite)
  • 4.6.1. Full-thickness (composite) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Synthetic Skin Substitutes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Synthetic Skin Substitutes Market: Application Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Synthetic Skin Substitutes Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Diabetic foot ulcers (DFUs)
    • 5.4.2.1. Diabetic foot ulcers (DFUs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Pressure ulcers
    • 5.4.3.1. Pressure ulcers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Venous leg ulcers (VLUs)
    • 5.4.4.1. Venous leg ulcers (VLUs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Acute Wounds
  • 5.5.1. Acute wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Surgical wounds
    • 5.5.2.1. Surgical wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Burn Injuries
    • 5.5.3.1. Burn Injuries market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Synthetic Skin Substitutes Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Synthetic Skin Substitutes Market: End use Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Synthetic Skin Substitutes Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Ambulatory Surgical Centers (ASCs)
  • 6.5.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Specialty Clinics & Wound Care Centers
  • 6.6.1. Specialty clinics & wound care centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Synthetic Skin Substitutes Market: Regional Estimates & Trend Analysis by Anatomical Replacement Area, Application and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. South Africa synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Saudi Arabia synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. UAE synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait synthetic skin substitutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Type Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Integra LifeSciences Corporation
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. PolyNovo Limited
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. PolyMedics Innovations GmbH
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. RenovoDerm (ParaGen Technologies)
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Smith+Nephew
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. ETS Wound Care
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Organogenesis Inc.
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. AVITA Medical, Inc.
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives